AIM
SRDX

Aigen Investment Management’s Surmodics SRDX Stock Holding History

Aigen Investment Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,495
Closed -$150K – 1250
2020
Q1 		$150K Buy
4,495
+1,595
+55% +$57.6K 0.02% 789
2019
Q4 		$120K Buy
+2,900
New +$122K 0.02% 647

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Aigen Investment Management's SRDX Position: Q2 2020 in Review

Aigen Investment Management sold out of Surmodics (SRDX) in Q2 2020, closing a stake of 4,495 shares — an estimated $150K sold.

Aigen Investment Management first reported a position in SRDX in Q4 2019 and held it in 2 quarters. The position peaked at $150K in Q1 2020. 135 funds tracked by Wall St. Rank hold SRDX as of Q2 2020.

  • Aigen Investment Management reported no remaining Surmodics position as of Q2 2020 after selling out during the quarter.
  • Aigen Investment Management sold 4,495 Surmodics shares in Q2 2020, an estimated $150K.
  • Aigen Investment Management first reported a position in Surmodics in Q4 2019 and held it in 2 quarters.
  • Aigen Investment Management's Surmodics position peaked at $150K in Q1 2020.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.